HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Investigation of peroxide modification of low- and very low-density lipoproteins in patients with coronary heart disease by the method of fluorescent spectroscopy].

Abstract
In the total fraction of low and very low density lipoproteins (LDL+VLDL) isolated from serum by precipitation in the presence of heparin-Mn the copper-induced lipid peroxidation was accompanied by accumulation of LPO products, a decrease ANS fluorescence intensity (F(ANS)) and an increase in probe--cation DSP-6, a fluorescence intensity decrease of intrinsic in the ultraviolet area (F(uv)) and an increase in the visible area (F(vis)). The degree of lipoprotein modification was estimated by calculating the F(vis)/F(uv) and F(DSP)-6/F(ANS) ratio. Strong positive correlation was found between these ratios and concentration of thiobarbituric acid-reactive substances (TBARS) of LDL+VLDL samples isolated from sera of 49 donors and incubated at 37 degrees C in the presence of 50 M CuSO4 during 0, 3 and 24 hr (F(vis)/F(uv) (r = 0.75; p < 0.001) and F(DSP-6)/F(ANS) (r = 0.73; p < 0.001)). Very strong positive correlation was also found between both fluorescent parameters F(vis)/F(uv) and F(DSP-6)/F(ANS) (r = 0.95, p < 0.001). Changes in the values of F(vis)/ F(uv), F(DSP-6)/F(ANS), concentration of TBARS in 75 patients with documented coronary heart disease (CHD) and 49 apparently healthy donors were studied. No significant differences of these parameters in LDL+VLDL of patients with CHD and donors were found.
AuthorsR K Aĭdyraliev, O A Igemberdieva, M Kh Dadabaev, T M Murataliev, K A Aĭtbaev, A A Aldashev
JournalBiomeditsinskaia khimiia (Biomed Khim) 2011 Jan-Feb Vol. 57 Issue 1 Pg. 127-32 ISSN: 2310-6972 [Print] Russia (Federation)
PMID21516784 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Fibrinolytic Agents
  • Lipoproteins, LDL
  • Lipoproteins, VLDL
  • Thiobarbituric Acid Reactive Substances
  • Manganese
  • Copper
  • Heparin
Topics
  • Copper (pharmacology)
  • Coronary Disease (blood)
  • Female
  • Fibrinolytic Agents (pharmacology)
  • Heparin (pharmacology)
  • Humans
  • Lipid Peroxidation (drug effects)
  • Lipoproteins, LDL (blood, chemistry)
  • Lipoproteins, VLDL (blood, chemistry)
  • Male
  • Manganese (pharmacology)
  • Spectrometry, Fluorescence
  • Thiobarbituric Acid Reactive Substances (analysis, chemistry)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: